Dr. Bracy Fertig, CEO and Co-Founder of oncology start-up, Orchestra, is unafraid of taking on big, important challenges. But she doesn’t go it alone. Bracy has mastered the art of bringing together the right stakeholders to fill in gaps in her own knowledge to improve important problems, such as oncology treatment and diagnostics. Listen now or read her profile.
Beats in the beginning and end by Dylan Sitts.
Skip ahead to sections relevant to you:
00:20-10:30—Bracy talks through her dream of becoming a doctor, her disillusionment with the clinical route, and her decision to start a PhD program.
11:00-14:00—How Bracy transitioned from her PhD program to healthcare investment banking.
14:00-15:20—How Bracy learned how to build trust with key stakeholders in the healthcare industry to execute on the most important transactions.
21:00-22:40—Why Bracy joined a Series C start-up, CareSyntax, as VP of Strategy.
25:00-26:00—How companies ensure success.
27:00-30:00—What Bracy’s oncology diagnostics start-up, Orchestra, does.
30:35-35:00—How Bracy identified the problem that Orchestra would solve and how she brought together the right stakeholders to solve it.
36:00-39:30—How Orchestra will align healthcare stakeholders to improve care and cost for oncology treatments.
40:00-42:12—How Orchestra is practically implementing this solution this year.
42:12-43:20—How Orchestra is testing the right entry point (customer) for their service.
43:45-44:45—How Bracy handles the ambiguity of starting a company within such a challenging, large, and emotional problem in the United States.
